JPRN-UMIN000021944招募中未知
The efficacy and safety of switching from linagliptin to once-weekly dulaglutide in hemodialysis patients with type 2 diabetes mellitus (pilot study) - The efficacy of linagliptin and dulaglutide in hemodialysis patients with type 2 diabetes mellitus
Minamisenju Hospital0 个研究点目标入组 20 人开始时间: 2016年4月26日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients with severe gastroparesis 2)The patient with the medical history of the pancreatitis 3)Patients who have a medical history of hypersensitivity 4)Pregnant or possibly pregnant women and women on lactation 5)Ineligible patients according to the investigator's judgment 6)The patients who do not agree with this study
研究者
相似试验
招募中
不适用
The efficacy and the utility of switching into glucagon like peptide-1 receptor agonist plus basal insulin therapy in type 2 diabetic patients treated with Basal-Bolus therapy.Type 2 diabetesJPRN-UMIN000032665Department of Endocrinology, Nippon Medical School Chiba Hokusoh Hospital100
尚未招募
不适用
Safety and efficacy of non-medical switching from originator infliximab to infliximab biosimilar CT-P13 in patients with inflammatory bowel diseaseJPRN-UMIN000043165Fukuoka University Chikushi Hospital220
进行中（未招募）
1 期
Assessing the safety and efficacy of switching to Azarga (Brinzolamide/Timolol Fixed Combination), as replacement therapy in patients with uncontrolled intraocular pressure - not applicableEUCTR2009-015795-10-SIAlcon d.o.o.120
已完成
不适用
Evaluation of the safety and efficacy in linagliptin with type 2 diabetic patients receiving hemodialysis therapytype 2 diabetes mellitusJPRN-UMIN000010099Saitama medical University50
已完成
不适用
Investigation of efficacy and safety of switching from basal-bolus therapy to combination therapy with GLP-1 receptor agonist and basal insulin injection in type 2 diabetestype 2 diabetesJPRN-UMIN000013222Juntendo University Graduate School of Medicine30